For semaglutide 1 , 74.8%, 54.8%, and 34.8% achieved those, while for tirzepatide [4] it was 90.1%, 78.2% and 62.9%
If you need more help, feel free to reach out
By emphasizing a holistic approach, she combines the medication with guidance on nutrition and exercise, ensuring the best possible outcome for your weight loss goals
Source: Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity In the OASIS 4 trial, gastrointestinal side effects were reported in 74.0% of people taking oral semaglutide 25mg, compared with 42.2% of people taking placebo
1 The pain benefit appears to follow the weight loss rather than the prescription, so if you maintain the weight loss through long-term habit change, the pain reduction is likely to persist